|Key people||Robert Hansen, CEO & President|
|Products||Speciality Chemicals, silicon derived polymers|
Dow Corning is an American multinational corporation headquartered in Midland, Michigan, USA. Dow Corning specializes in silicone and silicon-based technology, offering more than 7,000 products and services. Dow Corning is an equally owned joint venture of Dow Chemical and Corning. On November 13, 2014, Dow Chemical's CEO Liveris revealed in a presentation to investors that Corning Incorporated intended to exit the joint venture of 71 years, citing other priorities. It is speculated that Dow could be taking over the Corning's stake at Dow Corning. Liveris declined to disclose details.
Products developed over the years include silicone sealants, adhesives, silicone mold-making rubbers, lubricants, release agents for cookware, sound-absorbing silicone, leather treatment, skin care lotion, preceramic polymers for high temperature applications, liquid silicone drycleaning solvent, high-purity silicon wafers for use in semiconductors and solar panels, as well as silicone waxes.
In 1942, moisture in aircraft engines and the formation of corona discharge from aircraft electrical systems at high altitudes made high-altitude flight almost impossible. Dr. Shailer Bass developed Dow Corning's first product, a simple silicone grease (Dow Corning #4 Compound) that solved the problem. Dow Corning was formally established in 1943 specifically to explore the potential of silicones. Dr. E. C. Sullivan was named president, and Dr. William R. Collings was named general manager in 1943. Dr. Collings later became president from 1954 until 1962.
A large, majority-owned subsidiary of Dow Corning Corporation is the Hemlock Semiconductor Corporation. Founded in the 1960s before the computer revolution, it is still one of the world's leading manufacturers of high-purity polycrystalline silicon, which is sold in varying purity grades for use in both semiconductor silicon wafer manufacture and photovoltaics applications as solar cells.
Breast implant controversy
Throughout the 1980s and 1990s, class-action lawsuits claimed that Dow Corning's silicone breast implants caused systemic health problems. The claims first centered around breast cancer and then migrated to a range of autoimmune diseases, including lupus, rheumatoid arthritis and various neurological problems. This led to numerous lawsuits beginning in 1984 and culminating in a 1998 multibillion-dollar class action settlement. As a result, Dow Corning was in bankruptcy protection for nine years, ending in June 2004.
A number of large, independent reviews of the scientific literature, including the U.S. Institute of Medicine, have subsequently found that silicone breast implants do not appear to cause breast cancers or any identifiable systemic disease.
- Dow Corning fast facts (June 13 2013)
- "Dow Says Corning Wants to Exit 71-Year-Old Venture". bloomberg.com. bloomberg.com. Retrieved 16 November 2014.
- independent.co.uk - $2.4bn breast-implant offer, 1997-08-26
- "Panel Confirms No Major Illness Tied to Implants" (June 21, 1999), The New York Times
- Chronology of silicone breast implants. Frontline
- Colas, André; Curtis, Jim (2004). Biomaterials Science, Second Edition: An Introduction to Materials in Medicine. Elsevier, Academic Press. ISBN 978-0-12-582463-7.